What is Agenus Inc.'s Market Cap?

Agenus Inc.'s Market Cap is $285.0M, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s Enterprise Value?

Agenus Inc.'s Enterprise Value is $296.3M, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s Trailing P/E?

Agenus Inc.'s Trailing P/E is 3.1×, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s Price / Sales?

Agenus Inc.'s Price / Sales is 2.1×, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s EV / Revenue?

Agenus Inc.'s EV / Revenue is 2.2×, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s EV / EBITDA?

Agenus Inc.'s EV / EBITDA is 7.2×, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s Revenue (TTM)?

Agenus Inc.'s Revenue (TTM) is $132.7M, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s Net Income (TTM)?

Agenus Inc.'s Net Income (TTM) is $91.7M, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s EBITDA?

Agenus Inc.'s EBITDA is $40.9M, based on as-reported figures from SEC (XBRL) filings.

What is Agenus Inc.'s Diluted EPS (TTM)?

Agenus Inc.'s Diluted EPS (TTM) is 2.04, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Agenus Inc.

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001SDV370

6.33▼ 0.18 (-2.76%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 6.51
Day's Range: 6.16 – 6.50
52-Week Range: 2.71 – 10.31
Volume: 505.7K
Avg Volume: 1.0M

Share Statistics

Shares Outstanding
Employees: 81
Exchange: XNAS
Listed: 2000-02-04

Share count as of August 4, 2026

Agenus Inc. (AGEN) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Agenus Inc. (AGEN)

What is Agenus Inc.'s Market Cap?: Agenus Inc.'s Market Cap is $285.0M, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s Enterprise Value?: Agenus Inc.'s Enterprise Value is $296.3M, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s Trailing P/E?: Agenus Inc.'s Trailing P/E is 3.1×, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s Price / Sales?: Agenus Inc.'s Price / Sales is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s EV / Revenue?: Agenus Inc.'s EV / Revenue is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s EV / EBITDA?: Agenus Inc.'s EV / EBITDA is 7.2×, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s Revenue (TTM)?: Agenus Inc.'s Revenue (TTM) is $132.7M, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s Net Income (TTM)?: Agenus Inc.'s Net Income (TTM) is $91.7M, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s EBITDA?: Agenus Inc.'s EBITDA is $40.9M, based on as-reported figures from SEC (XBRL) filings.
What is Agenus Inc.'s Diluted EPS (TTM)?: Agenus Inc.'s Diluted EPS (TTM) is 2.04, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · AGENAs-filed SEC (XBRL) data